about
Cancer treatment in pregnant womenImpact of specific KRAS mutation in exon 2 on clinical outcome of chemotherapy- and radiotherapy-treated colorectal adenocarcinoma patients.Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome.High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.Melanin content in melanoma metastases affects the outcome of radiotherapy.An analysis of the prognostic value of IDH1 (isocitrate dehydrogenase 1) mutation in Polish glioma patients.Oxidative DNA damage--the possible use of biomarkers as additional prognostic factors in oncology.Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions.Prognostic and predictive significance of p53, EGFr, Ki-67 in larynx preservation treatment.Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers.IDH1 mutation analysis – an example of putative glioma marker.Small field radiotherapy of head and neck cancer patients is responsible for oxidatively damaged DNA/oxidative stress on the level of a whole organism.Relationship between Glioblastoma Dose Volume Parameters Measured by Dual Time Point Fluoroethylthyrosine-PET and Clinical Outcomes.8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients.Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients.Human Adipose-Derived and Amniotic Fluid-Derived Stem Cells: A Preliminary In Vitro Study Comparing Myogenic Differentiation Capability.Urinary 8-Oxoguanine as a Predictor of Survival in Patients Undergoing RadiotherapySevere oxidatively damaged DNA after cisplatin treatment of cancer patientsPrognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[F]fluoroethyl)-L-tyrosine (FET) PET imaging in glioblastoma multiformeEvaluation of treatment results and toxicity in cases of repeated radiation therapy of spinal metastasisAnalysis of Treg cell population alterations in the peripheral blood of patients treated surgically for ovarian cancer - a preliminary report[Predictive and prognostic value of p53, Ki-67 and EGFR in patients with advanced oral cavity and oropharyngeal cancer treated with induction chemotherapy]Potential survival markers in cancer patients undergoing chemotherapyEncapsulation for Cancer TherapyFDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma
P50
Q26770474-95451D5E-9F18-45FF-A26D-D8F1591D69F4Q34227451-021C0B54-4AA7-434D-A219-612820755C7EQ34727559-A7311770-8141-47F8-854E-4AFF48148B34Q36414198-FD62EFA1-2DCC-4CD9-B24E-329AE67A0DCFQ37109611-25714A96-84DF-4D6A-AA05-F25DB48499C8Q37506582-5139561C-11B1-40AE-B0E0-AB918D8969ABQ38175749-6A7B06FF-D789-4B87-9B14-1770B45B266AQ39195860-FCC499AC-B97A-4EA3-8994-D9723E9C7357Q42027389-3A1A315F-FD4C-4BBD-8932-718AE305356CQ43258112-1088B5EE-F2CE-4F49-9C33-BA5AE3389D70Q46250223-065E3B33-19F4-4D08-B777-713E7DDBBA0FQ46439258-A687CE6A-2A6D-4A76-A3B3-D3ACFFE6D193Q49770817-BC767FF3-02D2-4034-9315-4066A2DB8D89Q50853288-BA684F71-80A2-4EFE-9871-BD385033B0E8Q54939232-4C4B5B62-8DA3-478D-9FBE-496C248937EBQ55078053-246BF634-7612-4BB6-AD58-D08D60B6FE42Q60585019-674F6242-452A-4601-94DA-FB2D1C9ECC5EQ60585028-791224EB-BE4C-41C6-86C4-C50FA773C9A6Q64069621-65E071B2-E5B1-4D9B-9DBB-DCBB24AD0A67Q81473560-FE236BD1-32FD-4DBB-A631-26AB2B7EB891Q84220616-2F13B5DE-79E7-4A79-9860-2570044947A9Q84525551-3ED839BB-2A9A-47FE-918C-2AAF36E5D5E9Q85643646-91083376-6CD3-4F74-987C-E08CF9CE3DA1Q91542381-C1117841-8DF4-4BAA-B739-BB7F85C2A2BAQ93384702-A9F27BCF-822F-4D8F-AB3A-FA131D938D37
P50
description
hulumtues
@sq
onderzoeker
@nl
polski fizyk
@pl
researcher
@en
հետազոտող
@hy
name
Krzysztof Roszkowski
@ast
Krzysztof Roszkowski
@ca
Krzysztof Roszkowski
@cs
Krzysztof Roszkowski
@en
Krzysztof Roszkowski
@es
Krzysztof Roszkowski
@gl
Krzysztof Roszkowski
@hr
Krzysztof Roszkowski
@hsb
Krzysztof Roszkowski
@it
Krzysztof Roszkowski
@nl
type
label
Krzysztof Roszkowski
@ast
Krzysztof Roszkowski
@ca
Krzysztof Roszkowski
@cs
Krzysztof Roszkowski
@en
Krzysztof Roszkowski
@es
Krzysztof Roszkowski
@gl
Krzysztof Roszkowski
@hr
Krzysztof Roszkowski
@hsb
Krzysztof Roszkowski
@it
Krzysztof Roszkowski
@nl
prefLabel
Krzysztof Roszkowski
@ast
Krzysztof Roszkowski
@ca
Krzysztof Roszkowski
@cs
Krzysztof Roszkowski
@en
Krzysztof Roszkowski
@es
Krzysztof Roszkowski
@gl
Krzysztof Roszkowski
@hr
Krzysztof Roszkowski
@hsb
Krzysztof Roszkowski
@it
Krzysztof Roszkowski
@nl
P214
P106
P1153
8845264500
P1412
P1559
Krzysztof Roszkowski
@pl
P21
P214
P27
P2798
P31
P3124
P496
0000-0001-8722-1807
P734
P735
P7859
viaf-163925823